
Sign up to save your podcasts
Or


Phase I results of suprachoroidal delivery of a gene vector in treating neovascular AMD are promising. A discussion with Nikolas London, MD from Retina Consultant Group in San Diego CA & Scripps Memorial Hospital La Jolla.
By Retina Synthesis4.5
88 ratings
Phase I results of suprachoroidal delivery of a gene vector in treating neovascular AMD are promising. A discussion with Nikolas London, MD from Retina Consultant Group in San Diego CA & Scripps Memorial Hospital La Jolla.

18 Listeners

2,446 Listeners

112,734 Listeners

673 Listeners

56,473 Listeners

594 Listeners

4 Listeners

11 Listeners

52 Listeners

10 Listeners

18 Listeners

1 Listeners

0 Listeners

710 Listeners